Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Is JAKKS Pacific, Inc. (JAKK) a Good Buy?

Page 1 of 2

Before we spend many hours researching a company, we’d like to analyze what hedge funds and billionaire investors think of the stock first. We would like to do so because the elite investors’ consensus returns have been exceptional. The top 30 S&P 500 stocks among hedge funds at the end of September 2014 yielded an average return of 9.5% during the last 12 months ending in October 30. Sixty three percent of these 30 stocks outperformed the market. Although the elite funds occasionally have their duds, such as Micron and Anadarko Petroleum, which fell 50% and 26%, respectively during the same time period, the hedge fund picks seem to work on average. In the following paragraphs, we find out what the billionaire investors and hedge funds think of JAKKS Pacific, Inc. (NASDAQ:JAKK).

Is JAKKS Pacific, Inc. (NASDAQ:JAKK) worth your attention right now? Hedge funds are buying. The number of long hedge fund positions moved up by 2 in recent months. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Calamos Asset Management, Inc (NASDAQ:CLMS), Medley Management Inc (NYSE:MDLY), and Pernix Therapeutics Holdings Inc (NASDAQ:PTX) to gather more data points.

Follow Jakks Pacific Inc (NASDAQ:JAKK)
Trade (NASDAQ:JAKK) Now!

Keeping this in mind, let’s review the fresh action surrounding JAKKS Pacific, Inc. (NASDAQ:JAKK).

Hedge fund activity in JAKKS Pacific, Inc. (NASDAQ:JAKK)

At the end of the third quarter, a total of 16 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 14% from one quarter earlier. With the smart money’s positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were upping their holdings significantly (or already accumulated large positions).

When looking at the institutional investors followed by Insider Monkey, Renaissance Technologies, managed by Jim Simons, holds the biggest position in JAKKS Pacific, Inc. (NASDAQ:JAKK). Renaissance Technologies has a $17.5 million position in the stock, comprising less than 0.1% of its 13F portfolio. On Renaissance Technologies’s heels is Yale M. Fergang and Robert W. Medway of Royal Capital, with a $3.5 million position; the fund has 9.3% of its 13F portfolio invested in the stock. Remaining peers that hold long positions contain Ken Grossman and Glen Schneider’s SG Capital Management, John Overdeck and David Siegel’s Two Sigma Advisors and Peter Muller’s PDT Partners.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!